Literature DB >> 27849608

Transposon mutagenesis identifies genes that cooperate with mutant Pten in breast cancer progression.

Roberto Rangel1, Song-Choon Lee2, Kenneth Hon-Kim Ban2,3, Liliana Guzman-Rojas1, Michael B Mann1, Justin Y Newberg1, Takahiro Kodama1, Leslie A McNoe4, Luxmanan Selvanesan4, Jerrold M Ward2, Alistair G Rust5, Kuan-Yew Chin2, Michael A Black4, Nancy A Jenkins1,2, Neal G Copeland6,2.   

Abstract

Triple-negative breast cancer (TNBC) has the worst prognosis of any breast cancer subtype. To better understand the genetic forces driving TNBC, we performed a transposon mutagenesis screen in a phosphatase and tensin homolog (Pten) mutant mice and identified 12 candidate trunk drivers and a much larger number of progression genes. Validation studies identified eight TNBC tumor suppressor genes, including the GATA-like transcriptional repressor TRPS1 Down-regulation of TRPS1 in TNBC cells promoted epithelial-to-mesenchymal transition (EMT) by deregulating multiple EMT pathway genes, in addition to increasing the expression of SERPINE1 and SERPINB2 and the subsequent migration, invasion, and metastasis of tumor cells. Transposon mutagenesis has thus provided a better understanding of the genetic forces driving TNBC and discovered genes with potential clinical importance in TNBC.

Entities:  

Keywords:  Sleeping Beauty; TRPS1; breast cancer; metastasis; tumor suppressors

Mesh:

Substances:

Year:  2016        PMID: 27849608      PMCID: PMC5137755          DOI: 10.1073/pnas.1613859113

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  72 in total

Review 1.  Triple-negative breast cancer.

Authors:  William D Foulkes; Ian E Smith; Jorge S Reis-Filho
Journal:  N Engl J Med       Date:  2010-11-11       Impact factor: 91.245

Review 2.  The functions and regulation of the PTEN tumour suppressor.

Authors:  Min Sup Song; Leonardo Salmena; Pier Paolo Pandolfi
Journal:  Nat Rev Mol Cell Biol       Date:  2012-04-04       Impact factor: 94.444

3.  The gene associated with trichorhinophalangeal syndrome in humans is overexpressed in breast cancer.

Authors:  Laszlo Radvanyi; Devender Singh-Sandhu; Scott Gallichan; Corey Lovitt; Artur Pedyczak; Gustavo Mallo; Kurt Gish; Kevin Kwok; Wedad Hanna; Judith Zubovits; Jane Armes; Deon Venter; Jalil Hakimi; Jean Shortreed; Melinda Donovan; Mark Parrington; Pamela Dunn; Ray Oomen; James Tartaglia; Neil L Berinstein
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-25       Impact factor: 11.205

4.  High incidence of breast and endometrial neoplasia resembling human Cowden syndrome in pten+/- mice.

Authors:  V Stambolic; M S Tsao; D Macpherson; A Suzuki; W B Chapman; T W Mak
Journal:  Cancer Res       Date:  2000-07-01       Impact factor: 12.701

5.  Genomic analysis of a spontaneous model of breast cancer metastasis to bone reveals a role for the extracellular matrix.

Authors:  Bedrich L Eckhardt; Belinda S Parker; Ryan K van Laar; Christina M Restall; Anthony L Natoli; Michael D Tavaria; Kym L Stanley; Erica K Sloan; Jane M Moseley; Robin L Anderson
Journal:  Mol Cancer Res       Date:  2005-01       Impact factor: 5.852

Review 6.  PTEN and the PI3-kinase pathway in cancer.

Authors:  Nader Chalhoub; Suzanne J Baker
Journal:  Annu Rev Pathol       Date:  2009       Impact factor: 23.472

7.  GOBO: gene expression-based outcome for breast cancer online.

Authors:  Markus Ringnér; Erik Fredlund; Jari Häkkinen; Åke Borg; Johan Staaf
Journal:  PLoS One       Date:  2011-03-21       Impact factor: 3.240

8.  Combined genomic and phenotype screening reveals secretory factor SPINK1 as an invasion and survival factor associated with patient prognosis in breast cancer.

Authors:  Wendy Weijia Soon; Lance David Miller; Michael A Black; Cyril Dalmasso; Xiu Bin Chan; Brendan Pang; Chee Wee Ong; Manuel Salto-Tellez; Kartiki V Desai; Edison T Liu
Journal:  EMBO Mol Med       Date:  2011-06-08       Impact factor: 12.137

9.  Transcriptional repression of the Dspp gene leads to dentinogenesis imperfecta phenotype in Col1a1-Trps1 transgenic mice.

Authors:  Dobrawa Napierala; Yao Sun; Izabela Maciejewska; Terry K Bertin; Brian Dawson; Rena D'Souza; Chunlin Qin; Brendan Lee
Journal:  J Bone Miner Res       Date:  2012-08       Impact factor: 6.741

10.  Increased expression of TRPS1 affects tumor progression and correlates with patients' prognosis of colon cancer.

Authors:  Jun Hong; Jie Sun; Tao Huang
Journal:  Biomed Res Int       Date:  2013-05-26       Impact factor: 3.411

View more
  23 in total

1.  Plasminogen Activator Inhibitor 1 (PAI1) Promotes Actin Cytoskeleton Reorganization and Glycolytic Metabolism in Triple-Negative Breast Cancer.

Authors:  Brock A Humphries; Johanna M Buschhaus; Yu-Chih Chen; Henry R Haley; Tonela Qyli; Benjamin Chiang; Nathan Shen; Shrila Rajendran; Alyssa Cutter; Yu-Heng Cheng; Yu-Ting Chen; Jason Cong; Phillip C Spinosa; Euisik Yoon; Kathryn E Luker; Gary D Luker
Journal:  Mol Cancer Res       Date:  2019-02-04       Impact factor: 5.852

2.  Targeting TAZ-Driven Human Breast Cancer by Inhibiting a SKP2-p27 Signaling Axis.

Authors:  He Shen; Nuo Yang; Alexander Truskinovsky; Yanmin Chen; Ashley L Mussell; Norma J Nowak; Lester Kobzik; Costa Frangou; Jianmin Zhang
Journal:  Mol Cancer Res       Date:  2018-09-20       Impact factor: 5.852

3.  SB Driver Analysis: a Sleeping Beauty cancer driver analysis framework for identifying and prioritizing experimentally actionable oncogenes and tumor suppressors.

Authors:  Justin Y Newberg; Michael A Black; Nancy A Jenkins; Neal G Copeland; Karen M Mann; Michael B Mann
Journal:  Nucleic Acids Res       Date:  2018-09-19       Impact factor: 16.971

Review 4.  In vivo functional screening for systems-level integrative cancer genomics.

Authors:  Julia Weber; Christian J Braun; Dieter Saur; Roland Rad
Journal:  Nat Rev Cancer       Date:  2020-07-07       Impact factor: 60.716

5.  Transcriptional repressor GATA binding 1-mediated repression of SRY-box 2 expression suppresses cancer stem cell functions and tumor initiation.

Authors:  Xue Gong; Weiguang Liu; Lele Wu; Zhifang Ma; Yuzhi Wang; Shiyi Yu; Jun Zhang; Hao Xie; Guanyun Wei; Fei Ma; Ling Lu; Liming Chen
Journal:  J Biol Chem       Date:  2018-10-12       Impact factor: 5.157

6.  A single-copy Sleeping Beauty transposon mutagenesis screen identifies new PTEN-cooperating tumor suppressor genes.

Authors:  Jorge de la Rosa; Julia Weber; Mathias Josef Friedrich; Yilong Li; Lena Rad; Hannes Ponstingl; Qi Liang; Sandra Bernaldo de Quirós; Imran Noorani; Emmanouil Metzakopian; Alexander Strong; Meng Amy Li; Aurora Astudillo; María Teresa Fernández-García; María Soledad Fernández-García; Gary J Hoffman; Rocío Fuente; George S Vassiliou; Roland Rad; Carlos López-Otín; Allan Bradley; Juan Cadiñanos
Journal:  Nat Genet       Date:  2017-03-20       Impact factor: 38.330

7.  Trps1 transcription factor represses phosphate-induced expression of SerpinB2 in osteogenic cells.

Authors:  Mairobys Socorro; Apurva Shinde; Hajime Yamazaki; Sana Khalid; Daisy Monier; Elia Beniash; Dobrawa Napierala
Journal:  Bone       Date:  2020-10-03       Impact factor: 4.398

8.  Clinical significance and biological function of transcriptional repressor GATA binding 1 in gastric cancer: a study based on data mining, RT-qPCR, immunochemistry, and vitro experiment.

Authors:  Hong Wu; Zhiguang Huang; Menglan Huang; Yiwu Dang; Huiping Lu; Xingan Qin; Liang Liang; Lihua Yang; Jie Ma; Gang Chen; Zili Lv
Journal:  Cell Cycle       Date:  2020-10-12       Impact factor: 4.534

9.  SBCDDB: Sleeping Beauty Cancer Driver Database for gene discovery in mouse models of human cancers.

Authors:  Justin Y Newberg; Karen M Mann; Michael B Mann; Nancy A Jenkins; Neal G Copeland
Journal:  Nucleic Acids Res       Date:  2018-01-04       Impact factor: 16.971

10.  TRPS1 Suppresses Breast Cancer Epithelial-mesenchymal Transition Program as a Negative Regulator of SUZ12.

Authors:  Jing Hu; Peng Su; Meng Jiao; Xinnuo Bai; Mei Qi; Hui Liu; Zhen Wu; Jingtian Sun; Gengyin Zhou; Bo Han
Journal:  Transl Oncol       Date:  2018-02-20       Impact factor: 4.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.